Q3 EPS Estimate for Dolby Laboratories Boosted by Analyst

Dolby Laboratories, Inc. (NYSE:DLB - Free Report) - Equities research analysts at William Blair upped their Q3 2025 earnings per share estimates for Dolby Laboratories in a note issued to investors on Wednesday, November 20th. William Blair analyst R. Schackart now forecasts that the electronics maker will earn $0.52 per share for the quarter, up from their previous estimate of $0.43. The consensus estimate for Dolby Laboratories' current full-year earnings is $2.67 per share.

A number of other research firms have also recently issued reports on DLB. Barrington Research reaffirmed an "outperform" rating and issued a $100.00 price objective on shares of Dolby Laboratories in a research report on Wednesday, November 20th. Rosenblatt Securities increased their target price on Dolby Laboratories from $98.00 to $100.00 and gave the stock a "buy" rating in a research note on Wednesday, November 20th. Finally, StockNews.com upgraded Dolby Laboratories from a "buy" rating to a "strong-buy" rating in a research note on Monday, November 18th.

Dolby Laboratories Trading Down 0.0 %

Shares of DLB traded down $0.02 during mid-day trading on Monday, reaching $80.53. The company's stock had a trading volume of 387,355 shares, compared to its average volume of 406,336. Dolby Laboratories has a 1-year low of $66.35 and a 1-year high of $90.06. The stock has a market cap of $7.68 billion, a P/E ratio of 29.72 and a beta of 0.98. The business has a 50-day simple moving average of $74.33 and a two-hundred day simple moving average of $75.98.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in DLB. Boston Trust Walden Corp increased its position in Dolby Laboratories by 185.3% in the 3rd quarter. Boston Trust Walden Corp now owns 1,075,076 shares of the electronics maker's stock valued at $82,276,000 after buying an additional 698,283 shares in the last quarter. Clifford Capital Partners LLC increased its position in Dolby Laboratories by 3,114.7% in the 3rd quarter. Clifford Capital Partners LLC now owns 270,579 shares of the electronics maker's stock valued at $20,707,000 after buying an additional 262,162 shares in the last quarter. Acadian Asset Management LLC increased its position in Dolby Laboratories by 39.8% in the 2nd quarter. Acadian Asset Management LLC now owns 652,651 shares of the electronics maker's stock valued at $51,698,000 after buying an additional 185,884 shares in the last quarter. Dimensional Fund Advisors LP increased its position in Dolby Laboratories by 27.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 792,828 shares of the electronics maker's stock valued at $62,817,000 after buying an additional 168,744 shares in the last quarter. Finally, AQR Capital Management LLC increased its position in Dolby Laboratories by 16.2% in the 2nd quarter. AQR Capital Management LLC now owns 627,160 shares of the electronics maker's stock valued at $49,690,000 after buying an additional 87,298 shares in the last quarter. 58.56% of the stock is owned by institutional investors.

Insider Activity at Dolby Laboratories

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 28,512 shares of Dolby Laboratories stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $74.12, for a total transaction of $2,113,309.44. Following the transaction, the chief executive officer now directly owns 83,721 shares of the company's stock, valued at approximately $6,205,400.52. The trade was a 25.40 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Peter C. Gotcher sold 6,079 shares of Dolby Laboratories stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $78.96, for a total value of $479,997.84. Following the completion of the transaction, the director now directly owns 37,593 shares of the company's stock, valued at approximately $2,968,343.28. This trade represents a 13.92 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 39.54% of the stock is currently owned by company insiders.

Dolby Laboratories Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 10th. Investors of record on Tuesday, December 3rd will be issued a dividend of $0.33 per share. This is an increase from Dolby Laboratories's previous quarterly dividend of $0.30. The ex-dividend date is Tuesday, December 3rd. This represents a $1.32 annualized dividend and a dividend yield of 1.64%. Dolby Laboratories's dividend payout ratio (DPR) is 44.28%.

Dolby Laboratories announced that its Board of Directors has approved a share repurchase program on Wednesday, August 7th that authorizes the company to buyback $350.00 million in shares. This buyback authorization authorizes the electronics maker to purchase up to 5% of its shares through open market purchases. Shares buyback programs are often a sign that the company's board believes its stock is undervalued.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.